Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma is a research paper published in Neuro-Oncology Advances (2022). On theSindex it has a DataRank of 1.4. It has been cited 77 times, with 70 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.654
From this paper's citation signal
Citation Network Contribution
0.796
From 51 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 70 citers.
NIH
Grant: T32 CA009216
NIH
Grant: R01 CA238268
NIH
Grant: R25NS065743
NIH
Grant: K12CA090435
NIH
Grant: T32 #2T32CA071345-21A1
NIGMS
Grant: T32GM007753
NIGMS
Grant: T32GM144273
Lymphoma Research Foundation
Grant: 612757
NIAID NIH HHS
Grant: T32 AI007529
Curing Kids Cancer
Swim Across America
Neurosurgery Research & Education Foundation
Society for Immunotherapy of Cancer—AstraZeneca Postdoctoral Cancer Immunotherapy in Combination Therapies Clinical Fellowship Award
Cured Research Fellowship
Stand Up to Cancer Innovative Research Grant
The Jenny Fund
Damon Runyon Cancer Research Foundation
A Shot for Life
German Cancer Aid Mildred-Scheel Post-Doctoral Research Fellowship
Keywords